Goldman, Butterwick, Fitzpatrick And Groff

This study tests a topical serum called AGE serum on 50 post-menopausal women (ages 45-65) who are taking GLP-1 drugs like Ozempic or Wegovy, with half also on hormone therapy. The goal is to see if the serum safely improves skin firmness, fine lines, and radiance. Researchers wi…

This study tests whether a special nanodiamond cream (Pavise ECMR) helps the skin heal better after facial laser treatment for wrinkles and loose skin. Eight adults aged 35-70 will receive the cream on one side of their face and standard care on the other. Researchers will check …

This study tests Obagi Saypha MagIQ, a hyaluronic acid gel, in 100 adults aged 30-75 with mild-to-moderate facial aging. The gel is injected to treat volume loss, fine lines, and skin laxity. Researchers will measure improvement over 60 days using doctor and patient ratings.

This study tests whether adding epinephrine to a glycerin and lidocaine mixture improves the treatment of small leg veins (telangiectasias). Twenty adults will have one leg treated with the standard mixture and the other with the mixture plus epinephrine. Doctors will rate vein c…

This phase 2 trial tests whether injecting a hyaluronic acid filler (Skinvive) into the cheeks can improve skin quality in people taking GLP-1 weight loss medications. 24 women aged 25-50 will participate: 16 on GLP-1 drugs and 8 not on them. Researchers will measure changes in f…

This study tests a topical serum (AGE serum) to see if it safely improves visible signs of aging like fine lines, sagging, and dullness on the face and neck. It involves 25 non-menopausal adults aged 25-50 who have been taking GLP-1 agonist medications (such as Ozempic or Wegovy)…

This study tests whether Sculptra, a cosmetic injectable, can improve loose skin on the belly in people taking GLP-1 weight loss medications. Twenty women with mild to moderate skin laxity will receive Sculptra injections. Fifteen are on GLP-1 drugs, and five are not, to compare …